Rate My Professor Tanmoy Mondal

Mondal's research focuses on the pathobiology of chronic metabolic diseases and comorbidities such as type 2 diabetes, Alzheimer's disease, and metabolic dysfunction-associated steatotic liver disease, particularly health disparities in African American populations. He utilizes transcriptomic gene expression analysis for early disease biomarkers, studies radiation-induced genomic instability, DNA double-strand breaks, viral load quantification, and radioprotective properties of antioxidants like fermented black tea. His contributions include two funded projects from the National Cancer Institute and National Institute on Minority Health and Health Disparities. Key publications are 'Transcriptomic Analysis of Alzheimer's Disease Pathways in a Pakistani Population' (J Alzheimers Dis Rep, 2024), 'Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area' (Int J Mol Sci, 2023), 'Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area' (Diabetes Metab Res Rev, 2022), and 'Gene expression signatures in PCB-exposed Slovak children in relation to their environmental exposures and socio-physical characteristics' (Environ Sci Pollut Res Int, 2022). He co-authored a patent for a synergistic herbal composition from fermented black tea having radioprotection (Indian Patent No. 365840, 2019). Awards include CSIR Senior Research Fellowship (2018–2020), IUAC Junior Research Fellowship (2013–2015), GATE (2012, 2013), Best Paper awards at SNMICON and NMPAICON (2018), and Best Poster at Nano Bio Con (2016).